Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep704 | Obesity | ECE2017

Elevated serum adiponectin in Alzheimer’s disease as neuroprotective strategy

Letra Liliana , Rodrigues Tiago , Matafome Paulo , Duro Diana , Lemos Raquel , Patricio Miguel , Castelo-Branco Miguel , Baldeiras Ines , Seica Raquel , Santana Isabel

Background: Several studies have highlighted the contribution of adipose tissue dysfunction to the development and progression of Alzheimer’s Disease (AD), which may depend on alterations in adipokine secretion. Leptin and adiponectin are the most abundant adipokines in circulation, with recognized systemic effects, but also able to cross the blood-brain barrier and influence cognitive-related structures, such as the hippocampus.Objective: To determ...

ea0056gp201 | Pituitary Basic | ECE2018

Epigenetic and post-transcriptional regulation of the SSTR5 gene in somatotropinomas

Pedraza-Arevalo Sergio , Ibanez-Costa Alejandro , Vazquez-Borrego M Carmen , Branco Miguel , Galvez-Moreno M Angeles , Soto-Moreo Alfonso , Korbonits Marta , Gahete Manuel D , Charalambous Marika , Luque Raul M , Castano Justo P

The somatostatin receptor 5 (sst5) and its truncated splicing variants (sst5TMD5, sst5TMD4) are considered putative biomarkers that can predict pharmacological response or aggressiveness in several endocrine-related pathologies, such as acromegaly. sst5 is encoded by a gene, SSTR5, that lacks introns within its coding sequence, and hence, the splicing variants identified are generated by non-canonical splicing events. However, the mechanisms underlying their genesis a...